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The reaction of substituted aromatic aldehydes/ke-
tones with 5-methyl-l,3,4-thiadiazol- 2-ylthio/tetraiol-
l-ylacetic acid hydrazides (la-b) afford corresponding
hydrazones (2a-b-7a-b). The hydrazones (2a-b, 3a-b)
ontreatment with DMF/POCI3 under microwave irra-
diation (M.W.!.) afford corresponding pyrazoles (Sa-b,
9a-b). The hydrazones (4a-b, Sa-b) on reacting with
chloroacetylchloride/thioglycollic acid furnish corre-
sponding 2-azetidinones (IOa-b, Ha-b) and 4-thiazo-
lidinones (12a-b, 13a-b) respectively. The hydrazones
(6a-b, 7a-b) cyclise in the presence of polyphosphric
acid under M.W.I. to give corresponding benzopyran-
2-ones (14a-b, ISa-b). The hydrazides la-b on con-
densation with aromatic acids in the presence of thio-




benzopyran-2-ones and 1,3,4-oxadiazoles have
been extensively investigated by the organic che-
mists due to their close association with various
types of biological activities 1.4. In addition 1,3,4-
thiadiazoles and tetrazoles are themselves potent
antiviral and antifungal agentsv'. In recent time
there has been much interest for the use of micro-
wave irradiation (M.W.I.) in synthesis? due to sub-
stantial reduction in time.
In view of the potential biological activity of
above heterocycles and substantial reduction in
reaction time under M.Wl., it was of interest to
us to prepare the title compourids containing
1,3,4-thiadiazole and tetrazole moiety which are
side chains at C-3 and C-7 position of an antib-
iotic drug cefazolin sodium",
Results and Discussion
The synthesis of pyrazoles, 2-azetidinones
4-thiazolidinones, benzopyran-2-ones and 1,3,4-
Note
oxadiazoles is accomplished as shown in Scheme
I. Analytical and spectral data are given in Tables
I and Il.respectively,
5-Methyl-1, 3, 4-thiadiazol-2-ylthio/tetrazol-1-
ylacetic acid hydrazides (l a-b) were prepared ac-
cording to reported methodt-". These hydrazides
on condensation with substituted acetophenones
in ethanol with a trace of acetic acid furnished the
corresponding hydrazones (2a-b, 3a-b). IH NMR
spectra of these hydrazones displayed a singlet at
03.20-3.40 due to N = C - CH3 proton. These
hydrazones on reaction with DMF and POCI; un-
der microwave heating led to the formation of
(5' -methyl-l , 3, 4-thiadiazol- 2'-ylthioacetyl/tetra-
zol-Tvylacetyl} 3 -substituted phenyl-a-formyl py-
razoles (Sa-b, 9a-b). In IR spectrum a strong ab-
sorption band at 1680-1690 em -1 due to - CHO
group appeared and in IH NMR singlet at 09.60-
9.70 due to aldehydic proton appeared.
The hydrazides (la-b) on condensation with
substituted aldehydes in ethanol gave correspond-
ing hydrazones (4a-b, Sa-b). 1H NMR spectrum
of 4a and Sa displayed two characteristic singlets
at 08.50 and 8.40 due to -N=CH-proton.
These hydrazones on reaction with chloroacetyl
chloride and N-methyl morpholine" in microwave
oven afforded corresponding N-[5'-methyl-1, 3,
4":thiadiazol - 2'-ylthioacetarnidol tetrazol-I: -yla-
cetamido]- 3 -chloro- 4 {substituted phenyljazeti-
din-2-ones (lOa-b, lla-b). In IR spectrum of
these azetidinones absorption band in the region
1720-1735 cm-1 was assigned to cyclic> C=O
which is characteristic of ~lactam ring. In
1H NMR spectrum there were two doublets, one
at 03.5-3.6 due to - CH-proton at position-s in
the azetidin-Z-one ring and other at 04.3-4.7 due
to CH proton at position - 3 in the ring. The J va-
lue for C- 3 and C-4 protons lies between 1.9-2.0
Hz indicating tra~~lactam.
The hydrazones (4a-b, Sa-b) on condensation
with thioglycollic acid in DMF under microwave
irradiation furnished corresponding 2-(substituted
phenyl}-3-(5'-methyl-1, 3, 4-thiadiazol-2'-ylthio
acetamido/tetrazol-l '-ylacetamido)- 4 -thiazolidin-
ones (12a-b, 13a-b). The IR spectrum of thiazo-
lidinones showed a strong absorption band in the
region 1710-1730 cm-1 due to cyclic> c=o
group. In IH NMR spectrum a singlet appeared in
the region 03.4-3.5 due to - Cfl-proton of thiaz-
olidinone ring which is flanked by heteroatoms
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Table I-Physical data of compounds la-b-17a-b
Compd R RI Mol. m.p. Yield
formula" 0c) (%}
la MTD CsHsN4OS2 125-27 50
Ib lZA C3lIt.N6O 118-19 65
2a MID H CI3HI4N40S2 120-22 85
2b lZA H CuH12N60 127-28 88
3a MTD 4-Cl C13H13N4OS2Cl 175-77 98
3b lZA 4-Cl CIIHIIN60CI 170-72 96
4a MTD H CI2HI2N40S2 135-37 93
4b TZA H CioHION6O 140-41 90
Sa MTD 4-0CH3 C13HI4N402S2 120-22 97
Sb lZA 4-0CH3 CIIH12N606 128-30 95
6a MTD H C12H12N402S2 260-61 88
6b lZA H CioHION602 245-46 86
7a MTD 4-0CH3 C13HI4N403S2 254-55 92
7b lZA 4-0CH3 CIIH12N603 245-47 95
8a MTD H CIsH12N402S2 105-07 75
8b lZA H C13HION602 112-14 79
9a MTD 4-Cl CisHIIN402S2CI 155-58 80
9b lZA 4-Cl C13H~602CI 165-67 83
lOa MTD H CI4H13N402S2Cl 65-66 60
lOb lZA H C12HIIN602Cl 80-82 70
-Contd.
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Table I-Physical data of compounds hob, 17a-b,-Contd.
Compd R RI Mol. m.p. Yield
formula* 0c) (%)
lla MID 4-0CH3 CisHIsN403S2Cl 82-84 65
lIb TZA 4-0CH3 C13HI3N603Cl 90-92 69
12a MID H CI4HI4N402S3 160-62 59
12b TZA H C12H12N602S 157-59 66
13a MID 4-0CH3 CIsHI6N403S3 148-50 65
13b TZA 4-0CH3 CI3H14N603S 153-55 70
14a MID H CI2HsN202S2 240-41 55
14b TZA H CIOH6N4S2 235-36 60
15a MID 4-0CH3 C13HION203S2 225-27 58
15b TZA 4-0CH3 CllHsN403 229-30 68
16a MID H CI2HlON40S2 185-87 70
16b TZA H ClOH8N60 180-82 68
17a MID 4-Cl CI2H9N40S2CI 175-77 75
17b TZA 4-CI ClOH7N6OCI 172-74 80
*Satisfaetory elemental analysis (C, H & N) are obtained for all the compounds.
!
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Table II -Spectral data for compound 2a-b-17a-b
IHNMR(oppm)
2.70 (s, 3H, 5-CH3)' 3.20 (s, 3H, N = C-CH3)' 4.6 (s, 2H, SCH2), 6.6-7.0 (m, 5H, Ar-H),
8.9 (brs, IH, NH)
3.30 (s, 3H,N~C-CH3)' 6.40 (s, 2H, NCH2CO), 6.7-7.0 (m, 5H,Ar-H), 9.0 (brs, lH,
NH), 9.5 (s, 1H, 5'-H oftetrazole ring)
.2.70 (s, 3H, 5-CH3)' 3.20 (s, 3H, N = C-CH3)' 4.60 (s, 2H, SCH2), 6.9-7.2 (m, 4H, Ar-H)
9.0 (brs, tH, NH)
3.40 (s, 3H, N=C-CH3)' 6.40 (s, 2H, NCH2CO), 6.9-7.3 (m, 4H,Ar-H), 9.0 (brs, lH,
NH), 9.5 (s, 1H, 5'-H oftetrazole ring)
2.70 (5, 3H, 5-CH3)' 4.60 (5, 2H, SCH2), 6.6-7.0 (m, 5H, Ar-H), 8.5 (s, nr,CH = N),
8.9 (brs, nr,NH)
6.40 (s, 2H, NCH2CO), 6.6-7.1 (m, 5H,Ar-H), 8.60 (s, tH, CH=N), 8.9 (brs, in, NH),
9.5 (s, IH, 5'-H of tetrazole ring)
2.70 (s, 3H, 5-CH3)' 3.9 (5, 3H, 4-0CH3)' 4.6 (s, 2H, SCH2), 6.7-7.0 (m, 4H, Ar-H), 8.4 (5,
1H, CH = N), 8.9 (brs, tH, NH)
3.90(s, 3H, 4-0CH3)' 6.4 (s, 2H, NCH2CO),6;T·7.2 (m, 4H,Ar-H), 8.6 (s, tH, CH=N),
8.9 (brs, 1H, NH), 9.5 (s, 1H, 5'-H of tetrazole ring)
2.70 (s, 3H, 5-CH3)' 4.60 (s, 2H, SCH2), 4.8 (s, tH, Ar-OH), 6.9-7.4 (rn, 4H, Ar-H), 8.5 (s,
in, CH = N), 8.9 (brs, tH, NH)
4.80 (s, tH,Ar-OH), 6.40 (s, 2H, NCH2CO), 6.9-7.5 (m, 4H,Ar-H), 8.6 (s, tH, CH=N),
8.9 (brs, 1H, NH), 9:5 (s, lH, 5'-H oftetrazole ring) ..
2.70 (5, 3H, 5-CH3)' 4.0 (s, 3H, 4-0CH3), 4.6 (s, 2H, SCH2), 4.8 (s, tH, Ar-OH), 7.0-7.6
(m, 3H, Ar-H), 8.7 (s, lH, CH = N), 8.9 (brs, tH, NH)
3.90 (s, 3H, 4-0CH3),4.80 (s, in, Ar-OH), 6.4 (s, 2H, NCH2CO), 7.0-7.6 (m, 3H, Ar-H),
8.6 (s, lH, CH = N), 8.9 (brs, IH, NH), 9.5 (s, lH, 5'-H of tetrazole ring)
2.7 (s, 3H, 5-CH3), 4.50 (s, 2H, SCH2), 6.8-7.3 (m, 5H, Ar-H), 8.3 (s, lH, 5-CH of Pyra-
zole), 9.6 (s, LH, CHO)
6.40 (s, 2H, NCH2CO), 6.9-7.3 (m, 5H, Ar-H), 8.3 (s, tH, 5-CH of Pyrazole), 9.5 (s, lH,
5'-H oftetrazole ring), 9.7 (s, IH,CHO)
2.7 (s, 3H, 5~CH3)' 4.5 (s, 2H, SCH2), 7.1-7.5 (m, 4H, Ar-H), 8.4 (s, tH, 5-CH of Pyra-
zole), 9.6 (s, 1H, CHO)
6.4 (s, 2H, NCH2CO), 7.2-7.6 (m, 4H, Ar-H), 8.4 (s, tH, 5-CH of Pyrazole), 9.5 (s,
lH, 5'-H oftetrazole ring), 9.6 (s, IH, CRO)
-Contd.
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Table II-Spectral data for compound 2a-b-17a-b -{ Contd)




1725( C = 0 of ~lactam
ring),3200(NH)
1735(C = 0 of ~lactam
ring),3200(NH)








1730( C = 0, Coumarin),
1610 (3,4 double bond)
l720( C = 0, Coumarin),
1610 (3,4 double bond)
1730(C = 0, Coumarin),
1610(3,4 double bond)




12lO(C - 0 - C)
121O(C - 0 - C)
2.70 (s, 3H, 5-CH3), 3.5 (d, lH, 4-CH, J= 1.9 Hz), 4.30 (d, lH, 3-CH, J= 1.9 Hz), 4.6 (s,
2H, SCH2), 6.8-7.2 (m, 5H, Ar-H), 8.8 (brs, lH, NH)
3.6 (d, lH, 4-CH, J= 2.0 Hz), 4.5 (d, lH, 3-CH, J= 2.0 Hz), 6.4 (s, ZH, NCH2CO),
6.7-7.4 (m, 5H, Ar-H), 8.8 (brs, l.l-l, NH), 9.5 (s, l H, 5'-H oftetrazole ring)
2.70 (s, 3H, 5-CH3), 3.6 (d, lH, 4-CH, J= 2.0 Hz), 3.95 (s,3H, 4-0CH3), 4.45 (d, lH,
3-CH,J=2.0 Hz), 4.6 (s, 2H, SCH2), 6.8-7.3 (m, 4H,Ar-H), 8.9 (brs, lH, NH)
3.55 (d, lH, 4-CH, J= 2.0 Hz), 3.95 (s, 3H, 4-0CH3), 4.65 (d, lH, 3-CH, J= 2.0 Hz), 6.4
(s,
2H, NCH2CO), 6.8-7.3 (m, 4H, Ar-H), 8.9 (brs, lH, NH), 9.5 (s, lH, 5'-H oftetrazole
ring)
2.7 (s, 3H, 5-CH3), 3.40 (s, lH, 2-CH), 4.2 (s, 2H, 5-SCH2), 4.6 (s, 2H, 2-SCH2), 6.7-7.1
(rn, 5H, Ar-H), 8.9 (brs, lH, NH)
3.50 (s, lH, 2-CH), 4.3 (s, 2H, 5-SCH2), 6.4 (s, 2H, NCH2CO), 6.8-7.2 (rn, 5H,Ar-H),
8.9 (brs, 1H, NH) 9.5 (s, 1H, 5'-H of tetrazole ring)
2.7 (s, 3H, 5·CH3), 3.50 (s, lH, 2-CH), 3.80 (s, 3H, 4-0CH3), 4.35 (s, 2H, 5-SCH2),
4.60 (s, 2H, 2-SCH2), 6.6-7.1 (m, 4H, Ar-H), 8.9 (brs, 1H, NH)
3.50 (s, lH, 2-CH), 3.9 (s, 3H, 4-0CH3), 4.35 (s, 2H, 5-SCH2), 6.4 (s, 2H, NCH2CO),
6.9-7.3 (rn, 4H, Ar-H), 8.9 (brs, lH, NH), 9.5 (s, 1H, 5'-H of tetrazole ring)




6.9-7.5 (m, 4H, Ar-H), 8.4(s, lH, 4-H), 9.5 (s, lH, 5'-H of tetrazole ring) I
2.70 (s, 3H,5-CH3), 3.9 (s, 3H, 4-0CH3), 6.8-7.3 (rn, 3H, Ar-H), 8.3 (s, lH,4-H)
3.90 (s, 3H, 4-0C~3)' 6.9-7.4 (m, 3H, Ar-H), 804 (s, lH, 4-H), 9.5 (s, lH, 5'-H of tetrazole
ring
2.7 (s, 3H, 5-CH3), 4.6 (s, 2H, SCH2), 6.7-7.1 (m, 5H, Ar-H)
6.40 (s, 2H, NCH2CO), 6.9-7.4 (m, 5H, Ar-H), 9.5 (s, lH, 5'-Hoftetrazole ring)
2.7 (s, 3H, 5-CH3), 4.6 (s, 2H, SCH2), 6.8-7.3 (m, 4H, Ar-H)
6.40 (s, 2H, NCH2CO), 7.0-7.5 (m, 4H, Ar-H), 9.5 (s, 1H, 5'-H of tetrazole ring)
(nitrogen and sulphur) from two sides and with
benzene on third side. A singlet at 04.2-4.4 was
assigned to - C1h proton in the thiazolidinone
ring at position-5.
The hydrazides (la-b) on condensation with
2-hydroxy-arylaldehydes in ethanol afforded
corresponding hydrazones (6a-b, 7a-b). IH NMR
spectrum of 6aand 7a showed two characteristic
singlets at 08.50 and 8.70 due to - N = CH-pro-
ton respectively. These hydrazones were cyclised
in polyphosphoric acid using microwave heating
to furnish corresponding 3-(5'-methyl-l ,3,4-thiadi-
azol- 2' -ylthio/tetrazol-l '-yl)-2H-1-benzopyran- 2-
ones (14a-b, ISa-b). The IR spectrum of benzo-
pyranones showed absorption band at 1720-1730
(coumarin C=O) and 1600-1610 cm-I (3,4-dou-
ble bond of .coumarin) 12. In IH NMR spectrum a
singlet at 08.2-8.4 was observed for H-4 of ben-
zopyranone ring.
The hydrazides (1a-b) on cyclocondensation
with aromatic acids in the presence of thionyl
chloride under microwave irradiation yielded
2-(5'-methyl-1, 3, 4-thiadiazol-2'-ylthio methyl!
tetrazol-l '-ylmethyl)-5-(substituted phenyl)-1,3,4-
oxadiazoles (16a-b, 17a-b). The conversions were
monitored by the disappearance of C = 0 stretch-
ing frequency at 1690-1710 em-I. In IH NMR
spectrum of these oxadiazoles multiplet at 06.7-
7.5 appears due to aromatic protons.
Experimental section
Melting points were taken on Thomas Hoover
apparatus and are uncorrected. The IR spectra
(vmax in em -I) of synthesised compounds were re-
corded on 1710 Perkin Elmer FTIR spectropho-
tometerusing KBr discs and IHNMR on FT NMR
Hitachi R-600 using TMS as internal reference
(chemical shifts in 0,ppm).
1-(5-Methyl-l, 3, 4-thiadiazol-2-ylthio methyl/
tetrazol-L-ylmethyl) hydrazones (2a-b, 3a-b). A
solution of hydrazides (la-b) (0.01 mole) and sub-
stituted acetophenone (0.01 mole) in ethanol (20
mL) with few drops of glacial acetic acid in a 100
mL beaker was subjected to M.W.I. for 2-3 min.
The reaction mixture was cooled. The solid that
separated on cooling was filtered washed with
cold ethanol, dried and recrystallised from etha-
nol to give 2a-b, 3a-b.
1-(5' -Methyl-I, 3, 4-thiadiazol- 2' -ylthioacetyll
tetrazol-L' -ylacetyl)2-(substituted benzal) hydra-
zine (4a-b-7a-b). Hydrazide (0.01 mole) and ary-
laldehyde (0.01 mole) were taken in ethanol (15
mL) in a 100 mL beaker. The beaker was
zapped" inside a microwave oven for 1.5-2.0 min
at 2450 Hz. The reaction mixture was cooled and
the solid separated was filtered, washed with cold
ethanol and recrystallised from ethanol to give
4a-b-7a-b.
1-(5' -Methyl-I, 3, 4-thiadiazol- 2' -ylthioacetol
tetrazol-L' -ylaceto )-3-(substituted phenyl)4-for-
myI pyrazole (Sa-b, 9a-b). To the Vilsmeir-Haack
complex, prepared from DMF (10 mL) and
POCl3 (0.012 mole) at O°C, the hydrazone. (2a-b,
3a-b) (0.004 mole) was added and the reaction
mixture was subjected to M.W.I. for 3-4 min. The
reaction mixture was cooled and poured into ice-
cold water. The product which separated on neu-
tralization with NaHC03 was filtered and recrys-
tallised from ethanol-DMF to obtain Ba-b, 9a-b.
N-(5' -Methyl-I, 3, 4-thiadiazol- 2'ylthioacetam-
ldo/tetrazol-T -ylacetamido )-3 - chloro- 4 -(sub-
stituted phenyl) azetidin-2-ones (lOa-b, 11a-b).
A mixture of hydrazone (4a-b, Sa-b) (0.01 mole),
chloroacetyl chlo ride (0.015 mole) and N-methyl
morpholine (0.03 mole) in chlorobenzene (20 mL)
taken in a conical flask capped with a glass funnel
was zapped inside a microwave oven for 6-8 min.
A 500 mL beaker containing 200 mL water was
placed in the oven next to the reaction flask to
serve as "heat sink". The inorganic salt formed
was filtered and the filtrate was concentrated and
the residue was purified by column chromatogra-
phy (cWoroform-ethyl acetate, 1: 1) to obtain
lOa-b, Ha-b.
2-(Substituted phenyl)-3-(5' -methyl-I ,3,4-thia-
diazol- 2' -ylthio acetamido/tetrazol-L' -ylacetami-
do)-4-thiazolidinones (12a-b, 13a-b). A solution
of hydrazones (4a-b, Sa-b) (0.01 mole), thiogly-
collie acid (0.01 mole) and ZnCl2 (Ig) in DMF
(10 mL) was irradiated under M.W.I. for 4-5 min.
The reaction mixture was cooled, poured into ice-
cold water. The solid separated was filtered,
I
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washed with cold ethanol, dried and recrystallised
from ethanol- DMF to obtain l2a-b, 13a-b.
3-(5'-Methyl-l, 3, 4-thiadiazol- 2'- ylthio/tet-
razol-T -yl)- 2H -J-substituted benzopyran- 2-
ones (14a-b, l5a-b). Hydrazone (6a-b, 7a-b)
(0.01 mole) and polyphosphoric acid (10 mL)
were taken in a beaker. It was zapped inside a
microwave over for 3-4 min. The reaction mix-
ture was cooled and poured over crushed ice.
The solid separated was filtered and recrystallised
from acetone-ethanol (1 : 1) to get l4a-b, l5a-
b).
2-(5' -Methyl-l ,3, 4-thiadiazol- 2' -ylthiomethyll
tetrazol-L' -ylmethyl)-5-substituted phenyl-I ,3,4-
oxadiazoles (16a-b, 17a-b). A mixture of hydra-
zide (la-b) (0.01 mole), substituted aromatic acid
(0.01 mole) and thionyl chlo ride (10 mL) was irra-
diated under M.W.!. for 6-7 min. Excess of thio-
nyl chloride was distilled off under reduced pres-
sure. The residue was poured into ice-cold water
and neutralised with NaHC03 solution. The solid
separated was filtered, washed with cold water,
dried and recrystallised from chloroform to ob-
tain l7a-b, lSa-b.
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